Volume 62, Pages S68-S72 (December 2002)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Stephen P. McDonald, Graeme R. Russ Kidney International

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Renal manifestations in Fabry disease and therapeutic options

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Epidemiology of diabetic nephropathy in Spain

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Kidney transplantation in a low-resource setting: Nigeria experience

Progression of renal failure and hypertensive nephrosclerosis

Burden of chronic kidney disease: North Africa

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Volume 70, Pages S21-S25 (December 2006)

Volume 63, Issue 4, Pages (April 2003)

Volume 66, Issue 3, Pages (September 2004)

George A. Kaysen, Burl R. Don

End-stage renal disease in living kidney donors

Anemia as a risk factor for chronic kidney disease

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

Fernando Valderrábano, Francisco Gómez-Campderá, Elizabeth H.P. Jones

Renal risk scores: Progress and prospects

The epidemiology of chronic kidney disease

Prevention of renal failure: The Malaysian experience

Study of Heart and Renal Protection (SHARP)

Acute myocardial infarction in patients with end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Volume 67, Pages S48-S51 (January 2005)

Volume 65, Issue 6, Pages (June 2004)

Volume 69, Issue 9, Pages (May 2006)

Volume 68, Pages S4-S10 (August 2005)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Nephrology in Latin America, with special emphasis on Brazil

AGEs in foods: Do they play a role in uremia?

Volume 76, Issue 8, Pages (October 2009)

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Measurement of renal function in pre-ESRD patients

Prehypertension: is it relevant for nephrologists?

Homocysteine, renal function, and risk of cardiovascular disease

Stephen P. McDonald, Graeme R. Russ Kidney International

Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors Barry M. Brenner, Joann Zagrobelny

ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial

Peritoneal dialysis in Mexico

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Phosphate binders on iron basis: A new perspective?

Clinical benefits of slowing the progression of renal failure

Volume 55, Pages S3-S16 (June 1999)

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Renal replacement therapy in Latin America

Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Renal vascular disease in the elderly

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Prediction in idiopathic membranous nephropathy

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 62, Pages S68-S72 (December 2002) Losartan reduces the burden and cost of ESRD: Public health implications from the RENAAL study for the European Union William C. Gerth, Giuseppi Remuzzi, Giancarlo Viberti, Thierry Hannedouche, Alberto Martinez-Castelao, Shahnaz Shahinfar, George W. Carides, Barry Brenner Kidney International Volume 62, Pages S68-S72 (December 2002) DOI: 10.1046/j.1523-1755.62.s82.14.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Cumulative number of days with end-stage renal disease (ESRD) per patient by duration of follow-up. Symbols are: (dashed line) placebo; (solid line) losartan. Kidney International 2002 62, S68-S72DOI: (10.1046/j.1523-1755.62.s82.14.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Estimated cumulative number of ESRD cases in the European Union (EU). Symbols are: (dashed line) placebo; (solid line) losartan. Kidney International 2002 62, S68-S72DOI: (10.1046/j.1523-1755.62.s82.14.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Estimated cumulative ESRD-related costs in the EU. Symbols are: (dashed line) placebo; (solid line) losartan. Kidney International 2002 62, S68-S72DOI: (10.1046/j.1523-1755.62.s82.14.x) Copyright © 2002 International Society of Nephrology Terms and Conditions